Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Teresa A Simon,1 John H Simon,1 Erin G Heaning,1 Andres Gomez-Caminero,1 Jahan P Marcu1,2 1Physicians Research Center, LLC, Toms River, NJ, USA; 2Marcu Enterprises, Jersey City, NJ, USACorrespondence: Teresa A Simon, Physicians Research Center, LLC, Toms River, NJ, 08753, USA, Tel +732 818-7900, Fax...
Main Authors: | Simon TA, Simon JH, Heaning EG, Gomez-Caminero A, Marcu JP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/delta-8-a-cannabis-derived-tetrahydrocannabinol-isomer-evaluating-case-peer-reviewed-fulltext-article-DHPS |
Similar Items
-
Delta-8 Tetrahydrocannabinol Product Impurities
by: Colleen L. Ray, et al.
Published: (2022-10-01) -
Industry-Based Misconceptions Regarding Cross-Pollination of Cannabis spp.
by: Kenneth J. Olejar, et al.
Published: (2022-01-01) -
Time Trends of Tetrahydrocannabinol (THC) in a 2008–2021 German National Survey of Hemp Food Products
by: Hannah Dräger, et al.
Published: (2022-02-01) -
Self-reported adverse events associated with ∆8 -Tetrahydrocannabinol (Delta-8-THC) Use
by: Eric C. Leas, et al.
Published: (2023-05-01) -
Chemical Characterization of 29 Industrial Hempseed (<i>Cannabis sativa</i> L.) Varieties
by: Sheyla Arango, et al.
Published: (2024-01-01)